Pacira Terms of Use - Zilretta

Pacira Terms of Use

Pacira BioSciences, Inc. has prepared this information in good faith based on current information reasonably available. No liability whatsoever is accepted and no representation, warranty or undertaking, express or implied, is or will be made by Pacira or any of Pacira’s affiliates, or any of their respective agents, directors, officers, employees, advisers, or representatives (“Agents”), for any information, projections, or any of the opinions contained herein, or for any errors, omissions or misstatements. Neither Pacira nor any of Pacira’s affiliates, nor any of their respective Agents makes or has authorized to be made any representations or warranties (express or implied) in relation to Pacira or this website or as to the truth, accuracy or completeness of the information contained on this website, or any other written or oral statement provided in connection herewith, (the “Data”).

Neither the issue of the Data nor any part of its contents constitutes an offer to sell or invitation to purchase any of the products or services or assets described herein or any of the same relating thereto (the “Products”), and no information set out in the Data or referred to in any other written or oral information provided in connection with the Products is intended to form the basis of any decision to enter into any agreement or transaction with respect to the Products. Neither the issue of the Data nor any part of its contents is to be taken as any form of commitment on the part of Pacira or any of Pacira’s affiliates, nor any of their respective Agents to proceed with any agreement or transaction with respect to the Products.

Neither Pacira nor any of Pacira’s affiliates, nor any of their respective Agents undertakes any obligation to provide you or any other party with access to any additional information or to update or correct any inaccuracies in or omissions with respect to the Data, and the right is reserved, without giving reason, at any stage and in any respect to amend any content or proposed timetable, and to terminate any procedure or discussions or negotiations with you or any prospective purchaser.

In no circumstances will Pacira nor any of Pacira’s affiliates, nor any of their respective Agents be responsible for any costs or expenses incurred in connection with any appraisal or investigation of the Products or the viewing or use of the Data, or for any other costs and expenses incurred by you or any prospective purchasers in connection with any agreement or transaction related thereto.

The Data should not be considered as a recommendation by Pacira, nor any of Pacira’s affiliates, nor any of their respective Agents to enter into any agreement or transaction related to the Products or for the viewing or use of the Data. You are recommended to seek your own scientific, clinical, medical, financial and other advice as you, in your sole discretion, deem necessary and appropriate and should rely solely on your own judgment, review and analysis in evaluating the Data and Products.

One injection. Three months of major knee pain relief is possible. Ask about the Z!

Indication and Important Risk Information

What is ZILRETTA?
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) is an extended-release corticosteroid approved to manage osteoarthritis knee pain. The benefits and risks of repeat injections have not been demonstrated.

Who should not receive ZILRETTA?
You should not receive a ZILRETTA injection if you are allergic to corticosteroids, triamcinolone acetonide, or any other component of the product.

What possible side effects of corticosteroids could occur with ZILRETTA?

 

  • Rare serious allergic reactions
  • Effects in the injected knee such as infection (with pain, swelling and restricted motion) or joint damage
  • Increased chance of getting an infection, and a decreased ability to fight an infection
  • Effects on hormone production. These effects can be reversible
  • Elevated blood pressure, sodium and water retention, and potassium loss
  • Intestinal perforation if you have certain gastrointestinal disorders
  • Weakening of bones
  • Changes in behavior or mood disturbances
  • Increased pressure inside the eye

What are the most common side effects of receiving a ZILRETTA injection?
In multiple clinical trials, the most common side effects seen in people taking ZILRETTA were joint pain, headache, joint swelling, back pain, sore throat and runny nose, upper respiratory tract infection, and bruising.

What should you tell your doctor BEFORE receiving a ZILRETTA injection?
Tell your doctor about all of the medications you are taking (including both prescription and over-the-counter medicines) and about any medical conditions, especially if you have high blood pressure, heart disease, ulcers, diverticulitis or other gastrointestinal disorders, kidney problems, diabetes, glaucoma, behavior or mood disorders, and/or infections.

What should you tell your doctor AFTER receiving a ZILRETTA injection?
Contact your doctor if you develop a fever or other signs of infection, have an increase in pain along with swelling of the injected knee, restriction of joint motion, or a general feeling of discomfort. Contact your doctor immediately if you are exposed to chicken pox or measles, or for any new or worsening changes in behavior or mood.

These are not all of the possible side effects with ZILRETTA or corticosteroid medications. Please see the full Prescribing Information at www.ZILRETTALabel.com/PI.pdf. Always contact your doctor if you have questions or experience any side effects.

You are encouraged to report side effects to the FDA: Call 1-800-FDA-1088 (332-1088), or visit www.fda.gov/medwatch. You may also report side effects to Pacira at 1-844-353-9466.